Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update. | World Allergy Organ J | 2022 | 35966894 | PubTator, text mining | PubMed |
| Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants. | Comput Struct Biotechnol J | 2022 | 35965661 | PubTator, text mining | PubMed |
| The unique role of innate lymphoid cells in cancer and the hepatic microenvironment. | Cell Mol Immunol | 2022 | 35962192 | PubTator, text mining | PubMed |
| Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast. | Int J Mol Sci | 2022 | 35955621 | PubTator, text mining | PubMed |
Dynamic changes in intrinsic subtype, immunity status, and risk score before and after neoadjuvant chemo- and HER2-targeted therapy without pCR in HER2-positive breast cancers: A cross-sectional analysis. | Medicine (Baltimore) | 2022 | 35945759 | PubTator, text mining | PubMed |
| Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma. | Cell Rep Med | 2022 | 35944530 | PubTator, text mining | PubMed |
| Protocol for profiling cell-centric assembled single-cell human transcriptome data in hECA. | STAR Protoc | 2022 | 35942342 | PubTator, text mining | PubMed |
| COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation. | Nat Commun | 2022 | 35941157 | PubTator, text mining | PubMed |
| Early B cell factor 4 modulates FAS-mediated apoptosis and promotes cytotoxic function in human immune cells. | Proc Natl Acad Sci U S A | 2022 | 35939714 | PubTator, text mining | PubMed |
| Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19. | RNA Biol | 2022 | 35938548 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma. | Front Immunol | 2022 | 35935940 | PubTator, text mining | PubMed |
| SARS-CoV-2 versus other minor viral infection on kidney injury in asymptomatic and mildly symptomatic patients. | Virulence | 2022 | 35924838 | PubTator, text mining | PubMed |
| Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer. | Ther Adv Med Oncol | 2022 | 35923923 | PubTator, text mining | PubMed |
| Proteome and phosphoproteome signatures of recurrence for HPV+ head and neck squamous cell carcinoma. | Commun Med (Lond) | 2022 | 35919862 | PubTator, text mining | PubMed |
| Single-cell and spatial mapping Identify cell types and signaling Networks in the human ureter. | Dev Cell | 2022 | 35914526 | PubTator, text mining | PubMed |
| NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer. | Front Immunol | 2022 | 35911687 | PubTator, text mining | PubMed |
| Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population. | Front Genet | 2022 | 35910207 | PubTator, text mining | PubMed |
| Neuroinflammation: Extinguishing a blaze of T cells. | Immunol Rev | 2022 | 35909230 | PubTator, text mining | PubMed |
| The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma. | Oncogenesis | 2022 | 35907904 | PubTator, text mining | PubMed |
| Impact of COVID-19 on male urogenital health: Success of vaccines. | Drug Discov Today | 2022 | 35905935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=57